Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Bernard Zinman, Steven M Haffner, William H Herman, Rury R Holman, John M Lachin, Barbara G Kravitz, Gitanjali Paul, Nigel P Jones, R Paul Aftring, Giancarlo Viberti, Steven E Kahn
The Journal of Clinical Endocrinology & Metabolism | ENDOCRINE SOC | Published : 2010
This work was supported by funds from GlaxoSmithKline from whom the academic members of the ADOPT Steering Committee (B. Z., S. M. H., W. H. H., R. R. H., J. M. L., G. V., and S. E. K.) received honoraria, consulting fees, and/or grant/research support.